Zulfiqar Rana, MD, MPH, FACP

Combo-pilling has been gaining appeal among dieters, doctors and pharmaceutical companies, in part because single diet drugs have not been a great success. After sibutramine (Meridia) was taken off the market last October, there was only one drug left that was approved by the FDA for treating obesity for more than a few weeks: orlistat (Xen-ical by prescription or Allī over the counter). But even though orlistat is the only long-term option for consumers, many dieters eschew it because they can experience side effects (oily stains on their underwear, for example) if they eat fat-heavy meals. To many, combo-pilling begins to seem like the answer…
Here is the link: http://fluentnews.com/s/26537673